The study of more than two million veterans with diabetes details GLP-1 RA use relating to 175 outcomes; without ...

Objective. Glucagon-like peptide-1 (GLP-1) has many effects on glucose homeostasis, and GLP-1 receptors are broadly represented in many tissues including the brain. Recent research in rodents ...

Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders.

Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform ...

Heptares was also first to solve the glucagon-like peptide 1 (GLP-1) receptor structure 7, which could enable the next generation of today’s blockbuster anti-obesity drugs. In 2015, Heptares was ...

G-protein coupled receptors ... and insulin/glucagon secretion are GPCRs, which in islets mediate the effects of many of the circulating factors, such as glucagon-like peptide-1, free fatty ...

This cohort study found that key sociodemographic, health care, and clinical factors are associated with receipt of semaglutide, a novel glucagon-like peptide-1 (GLP-1) receptor agonist medication, in ...

Recently, some experts have raised concerns that novel weight loss drugs – known as glucagon-like peptide-1 (GLP-1) receptor agonists ... "We suggest that cardiac structure and function ...

Adherence to glucagon-like peptide-1 receptor agonist treatment in type 2 diabetes mellitus: A nationwide registry study. Diabetes Obes Metab. 2024 Nov;26(11):5239-5250. Sridhar A, Khan D, Elliott JA, ...

Its structure comprises a sequence of ... activate receptors involved in energy balance, such as the glucagon-like peptide-1 (GLP-1) receptor, glucagon receptor (GCGR), and glucose-dependent ...